Better times ahead for the biopharma sector? Could be, the new numbers say
Karen Carey, BioWorld’s managing editor and senior data analyst, and Tim Shannon, a general partner at Canaan, break down the numbers from first quarter of 2023.
Hosted on Acast. See acast.com/privacy for more information.
You Might Like
